Effect of Vitamin D Supplementation as Adjuvant Therapy in Neonatal Jaundice in Combination With Phototherapy

Muhammad Aamir Latif100 enrolled

Overview

Neonatal jaundice frequently occur during initial week of life. Neonatal jaundice is one of the leading causes of hospital admission and readmission. Some studies have suggested that the healthy newborns with hyperbilirubinemia outside the physiological range have notably reduced serum vitamin D levels. This deficiency is inversely associated with neonatal hyperbilirubinemia, suggesting that low vitamin D levels could be a potential risk factor for jaundice among neonates.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Neonatal Jaundice

Interventions

Vitamin DDRUG

Vitamin D supplementation as vitamin D, 2 drops i.e., 800 IU daily for 5 days.

Eligibility

Sex: ALLMin age: 3 DaysMax age: 28 Days

Medical Language ↔ Plain English

Inclusion Criteria: * Both genders * Admitted between 3-28 days of age. * Indirect hyperbilirubinemia with TSB levels between 14-20 mg/dL * Born via either cesarean or vaginal delivery * Birth weight greater than 2500 grams Exclusion Criteria: * Prior phototherapy treatment * Preterm birth (gestational age below 37 weeks). * SpO2 \< 95% at the time of admission * Severe respiratory distress or failure * Neonatal sepsis * Congenital anomalies * Parents/guardians unwilling to let their neonates be part of this study.

Locations (1)

Pediatric Medicine Department University of Child Health Sciences, Children's Hospital Lahore

Lahore, Pakistan

Outcomes

Primary Outcomes

Total Serum bilirubin levels

Total Serum bilirubin levels evaluated

Time frame: 5 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.